Stem cells and stem cell transplantation

Haematologica

Volumn 81, Issue 6, 1996, Pages 573-587

  Carlo Stella, Carmelo ^a   Tabilio, Antonio ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Stem cell transplantation; Stem cells

Indexed keywords

ARTICLE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; NONHUMAN; STEM CELL TRANSPLANTATION;

COLONY-FORMING UNITS ASSAY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION CONDITIONING;

EID: 0030326143     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (93)

1. Appelbaum FR. Marrow transplantation for hematologic malignanices: a brief review of current status and future prospects. Semin Hematol 1988; 25 (suppl 3): 16-22.
2. Borgna-Pignatti C. Bone marrow transplantation for the haemoglobinopathies. In: Treleaven J, Barrett J, eds. Bone Marrow Transplantation in practice. Edinburgh:Churchill Livingstone, 1992:151-9.
3. Gordon MY, Greaves MF. Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis. Bone Marrow Transplant 1989; 4:335-8.
4. Micklem HS, Anderson N, Ross E. Limited potential of circulating haemopoietic stem cells. Nature 1975; 256:41-3.
5. Eaves CJ. Peripheral blood stem cells reach new heights. Blood 1993; 82:1957-9.
6. Gordon MY. Physiological mechanisms in BMT and haemopoiesis - revisited. Bone Marrow Transplant 1993; 11:193-7.
7. Dexter TM. Regulation of hemopoietic cell growth and development: experimental and clinical studies. Leukemia 1989; 3:469-74.
8. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haemopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-5.
9. Scott MA, Gordon MY. In search of the haemopoietic stem cell. Br J Haematol 1995; 90:738-43.
10. Carlo-Stella C, Rizzoli V. Stem cells and stem cell factor(s). Haematologica 1995; 80:1-4.
11. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339:27-30.
12. Orlic D, Bodine DM. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC stand up! Blood 1994; 84:3919-4.
13. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81:2844-53.
14. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371:221-6.
15. Sutherland HI, Eaves CJ, Eaves AJ, Dragowskas W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74:1563-70.
16. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93:1470-4.
17. Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78:1-19.
18. Smith C, Gasparetto C, Collins NM, et al. Purification and partial characterization of a human hematopoietic precursor population. Blood 1991; 77:1218-27.
19. Gordon MY. Adhesive properties of haemopoietic stem cells. Br J Haematol 1988; 68:149-52.
20. Carlo-Stella C, Mangoni L, Piovani G, Garau D, Almici C, Rizzoli V. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83:1373-80.
21. Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133:157-65.
22. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989; 169:1721-31.
23. Sutherland RD, Keating A. The CD34 antigen: structure, biology and potential clinical applications. J Hematother 1992; 1:115-29.
24. Carlo-Stella C, Cazzola M, De Fabritiis P, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995; 80:367-87.
25. Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hematother 1993; 2:137-44.
26. Lansdorp PM, Sutherland HJ, Eaves CJ. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hematopoietic cells from human bone marrow. J Exp Med 1990; 172:363-6.
27. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89:2804-8.
28. Huang S, Terstappen LWMM. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR-, CD38-hematopoietic stem cells. Blood 1994; 83:1515-26.
29. Gunji Y, Nakamura M, Osawa H, et al. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood 1993; 82:3283-9.
30. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 1991;6:1641-50.
31. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65:1143-52.
32. Small D, Levenstein M, Kim E, et al. STK-1, the human homologue of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91:459-63.
33. Lyman SD, lames L, Van den Bos T, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75:1157-67.
34. Lyman SD, James L, Johnson L, et al. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994; 83:2795-801.
35. Hannum C, Culpepper J, Campbell D, et al. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994; 368:643-8.
36. Kmiecik TE, Keller JE, Rosen E, Vande Woude GF. Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 1992; 80:2454-7.
37. Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood 1993; 82:3515-23.
38. Eaves CJ, Cashman JD, Eaves AC. Methodology of long-term culture of human hematopoietic cells. J Tiss Cult Meth 1991; 13:55-62.
39. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994; 8:1095-104.
40. Gordon MY, Amos TAS. Stochastic effects in hemopoiesis. Stem Cells 1994; 12:175-9.
41. + hematopoietic stem cells. Blood 1994; 83:3758-79.
42. Gordon MY, Blackett NM, Lewis JL, Goldman JM. Evidence for a mechanism that can provide both short-term and long-term haemopoietic repopulation by a seemingly uniform population of primitive human haemopoietic precursor cells. Leukemia 1995; 9:1252-6.
43. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330:827-38.
44. Haas R, Murea S. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells. Cytokines Mol Ther 1995; 1:249-70.
45. Kessinger A, Smith DM, Strandjord SE, Landmark JD. Allogeneic transplantation of blood-derived, T cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4:643-6.
46. Russell NH, Hunter AE, Rogers S, et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 34:1482.
47. Dreger P, Suttorp M, Haferlach T, et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-7.
48. Majolino I, Aversa F, Bacigalupo A, Bandini G, Arcese W, Reali G. Allogeneic transpants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. Haematologica 1995; 80:40-3.
49. Hillyer CD, Wells SJ. Alternative sources of hematopoietic stem cells for bone marrow transplantation and rescue. J Hematother 1993; 2:491-9.
50. Saunders EF, Kapelushnik I, Solh H, Freedman MH. Graft vs host disease (GvHD) is reduced in allogeneic bone marrow transplantation (BMT) using marrow obtained surgically (Abstract). Blood 1990; 76(Suppl 1):563a.
51. Eastlund T, Cahill D, Fautsch S, Bennett S. Hematopoietic progenitors from human cadaveric vertebral body marrow. Preliminary results (Abstract). Blood 1990; 76(Suppl 1):536a.
52. Blazar BR, Lasky LC, Perentesis JP, et al. Successful donor engraftment in a recipient of bone marrow from a cadaveric donor. Blood 1986; 72:1655-60.
53. Lucas PJ, Quinones RR, Moses RD, et al. Alternative donor sources in HLA-mismatched marrow transplantation: T cell depletion of surgically resected cadaveric marrow. Bone Marrow Transplant 1988; 3:211-20.
54. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in patients with Fanconi anemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 1989; 321:1174-8.
55. Broxmeyer HE, Douglas GW, Hangor G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86:3828-32.
56. Harrison DE, Astle CM, Stone M. Numbers and functions of transplantable primitive immunohematopoietic stem cells. J Immunol 1987; 142:3833-9.
57. Broxmeyer HE, Hangoc G, Cooper S, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential transplantation in adults. Proc Natl Acad Sci USA 1991; 89:4109-13.
58. Payne A, Traycoff CM, Laver J, et al. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Bone Marrow Transplant 1995; 15:187-92.
59. Gerli R, Bertotto A, Crupi S, et al. Activation of cord blood T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. J Immunol 1989; 142:2583-9.
60. Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992; 89:1006-10.
61. de La Selle V, Gluckman E, Bruly-Rosset M. Newborn blood can engraft adult mice without inducing graft-versus-host-disease across non H-2 antigens. Blood 1996; 87:3977-83.
62. Almici C, Carlo Stella C, Wagner JE, Rizzoli V. Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical appliocation. Haematologica 1995; 80:473-9.
63. Rebel VI, Miller CI, Eaves CJ, Lansdorp PM. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their adult bone marrow counterparts. Blood 1996; 87:3500-7.
64. O'Reilly RJ, Pollack MS, Kapoor N, et al. Fetal liver transplantation in man and animals. In: Gale RP, Recent Advances in Bone Marrow Transplantation. New York:Alan R Liss, 1983; 799-830.
65. Meng PL, Frei RG. Gu DW, et al. Allogeneic fetal liver transplantation in acute leukemia. In: Gale RP, Tourraine JL, Lucarelli G, eds. Fetal liver transplantation. New York:Alan R. Liss, 1985; 281-91.
66. Prummer O, Fliedner TM. The fetal liver as an alternative stem cell source for hemolymphopoietic reconstitution. Int J Cell Cloning 1986; 4:237-49.
67. Fleming WH, Alpern EI, Uchida N, et al. Functional heterogenity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 1993; 122:897-902.
68. Siena S, Bregni M, Brando B, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74:1905-14.
69. Demirer T, Bensinger WI. Optimization of peripheral blood stem cell collection. Curr Opinion Hematol 1995; 2:219-26.
70. Gordon MY, Blackett NM. Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant 1995; 15:659-62.
71. Goggle JE, Gordon MY. Quantitative measurements on the haemopoietic system in three strains of mice. Exp Hematol 1975; 3:181-6.
72. Kernan NA, Flomenberg N , Dupont B, et al. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987; 43:842-7.
73. Kernan NA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T-cell-depleted bone marrow transplants correlate with development of graft-v-host-disease. Blood 1986; 68:770-3.
74. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell depleted haploidentical three loci incompatible transplants in leukemia patients by addition of rhG-CSF mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84:3948-55.
75. Fraser CC, Hoffman R. Hematopoietic stem cell behavior: potential implications for gene therapy. J Lab Clin Med 1995; 125:692-702.
76. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature 1990; 347:188-9.
77. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behaviour of hematopoietic stem cells. Cell 1986; 45:917-27.
78. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Develop 1990; 4:220-32.
79. Abkowitz JL, Linenberger ML, Newton MA, Shelton GH, Ott RL, Guttorp P. Evidence for the maintenance of hematopoiesis in a large animal by sequential activation of stem cell clones. Proc Natl Acad Sci USA 1990; 87:9062-6.
80. Tavassoli M, Hardy CL. Molecular basis of homing of intravenously transplanted stem cells to the marrow. Blood 1990; 76:1059-70.
81. Aurer I, Gale RP. Are new conditioning regimens for transplants in acute myelogenous leukemia better? Bone Marrow Transplant 1991; 7:255-62.
82. Slavin S, Ackerstein A, Naparstek E, Or R, Weiss L. The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplant 1990; 6:155-61.
83. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300:1068-73.
84. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75:555-62.
85. Mitsuyasu RT, Champlin RE, Gale RP, et al. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. Ann Intern Med 1986; 105:20-6.
86. Barrett AJ, Jiang YZ. Immune response to chronic myelogenous leukemia. Bone Marrow Transplant 1992; 9:305-11.
87. Bianco JA, Appelbaum FR. Biotherapy after marrow transplantation and the use of hematopoietic growth factors. Curr Opinion Oncol 1990; 2:289-96.
88. Champlin RE, Gale RP. The early complications of bone marrow transplantation. Semin Hematol 1984; 21:101-9.
89. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328:342-4.
90. Betticher DC, Huxol H, Mller R, Speck B, Nissen C. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Exp Hematol 1993; 21:1517-21.
91. Li S, Champlin R, Fitchen JH, Gale RP. Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. J Clin Invest 1985; 75: 234-41.
92. Martens ACM, Van Bekkum DW, Hagenbeek A. The BN acute myelocytic leukemia (BNML) (A rat model for studying human acute myelocytic leukemia (AML)). Leukemia 1990; 4:41-57.
93. Schultz FW, Martens ACM, Hagenbeek A. The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations. Leukemia 1989; 3:530-4.